MUC16
Assets acting on this target.
- Class
- MUC16-targeted
Related mechanisms
MUC16 drugs compared
2 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| 27T51 | Regeneron Pharmaceuticals | cell therapy | Phase 1 | Phase 1 in Ovarian Cancer |
| GSK5533524 | GlaxoSmithKline | antibody-drug conjugate | Phase 1 | Phase 1 in Advanced Solid Tumors |